Skip to main content
You are viewing an archived web page. The information on this web page may be out of date.

Monday, April 4, 2005

Chaired by: Patricia Grady, Story Landis, and Lawrence Tabak

  1. Dr. Tabak opened the meeting by noting the renewed interest in pain research by Congress and the re-introduction of a House Bill by Rep. Rogers of Michigan to, in part, establish a Pain Institute at the NIH. Dr. Landis described the NIH Neuroscience Blueprint Initiative. The Blueprint may be a useful means of helping to organize and fund pain-related projects planned by the Pain Consortium.
  2. Dave Thomas described draft plans for the Novel Pain Treatments Workshop. There was discussion about the intended audience for this meeting including attendance by the lay public, science writers, healthcare providers, educators, scientists, etc. and the matching of the topic areas and speakers to the appropriate audience. The possibility of breaking it up into two meetings was discussed. Stephen Groft will contact OMAR representatives regarding the requirements for developing a Technology Assessment Conference, or State of the Science Conference, or a Consensus Conference on pain. He will also obtain information on the time line for AHRQ to provide substantive reviews of the pain field. The possibility of holding a Science Writers Seminar also will be explored, and whether it would be appropriate to include patient advocates at that seminar.
  3. John Kusiak described draft plans for the NIH Pain Symposium noting that it is intended to highlight NIH-funded pain research and is geared to the scientific community.
  4. Dr. Tabak presented two new Initiatives to the group. One is a Migraine Headache proposal (Linda Porter will circulate a draft of it to the Committee for comment); the second is for Specialized Translational Pain Research Centers. Comments were made about the level of funding for each proposed Center, the possibility of seeking planning grants prior to actual funding of the Centers, and the seeking of funds from other Institutes besides those participating in the Neuroscience Blueprint.
  5. It was agreed that the Consortium should meet more frequently and Dr. Tabak suggested that John Kusiak and Linda Porter take responsibility for instituting a regular schedule for Consortium meetings.
  6. Action Items

The Consortium members should send additional comments and suggestions to John Kusiak and/or Linda Porter regarding the following:

  1. Speakers and Topics for the NIH Pain Consortium Symposium
  2. The Migraine Headache proposal
  3. The Specialized Translational Pain Research Centers proposal